The Nasdaq Now: Groupon Down Almost 10% With Nobody Happy that Andrew … – Minyanville.com
 Market Daily News |
The Nasdaq Now: Groupon Down Almost 10% With Nobody Happy that Andrew …
Minyanville.com BioCryst Pharmaceuticals (NASDAQ:BCRX) jumped 16.87% to $ 1.87. Traders were responding favorably to news that its planned merger with Presidio Pharmaceuticals had been called off. The likely cause of the merger termination was BioCryst's withdrawal … Groupon Inc. (NASDAQ:GRPN): The Main Problems With CEO Andrew Mason Is Groupon Inc (NASDAQ:GRPN)'s CEO a Big Issue? Groupon Inc (GRPN) CEO, Andrew Mason Threatens to Fire Himself |
